Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.

CONTEXT Vaccination with whole-cell pertussis vaccine carries an increased risk of febrile seizures, but whether this risk applies to the acellular pertussis vaccine is not known. In Denmark, acellular pertussis vaccine has been included in the combined diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine since September 2002. OBJECTIVE To estimate the risk of febrile seizures and epilepsy after DTaP-IPV-Hib vaccination given at 3, 5, and 12 months. DESIGN, SETTING, AND PARTICIPANTS A population-based cohort study of 378,834 children who were born in Denmark between January 1, 2003, and December 31, 2008, and followed up through December 31, 2009; and a self-controlled case series (SCCS) study based on children with febrile seizures during follow-up of the cohort. MAIN OUTCOME MEASURES Hazard ratio (HR) of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination and HR of epilepsy after first vaccination in the cohort study. Relative incidence of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination in the SCCS study. RESULTS A total of 7811 children were diagnosed with febrile seizures before 18 months, of whom 17 were diagnosed within 0 to 7 days after the first (incidence rate, 0.8 per 100,000 person-days), 32 children after the second (1.3 per 100,000 person-days), and 201 children after the third (8.5 per 100,000 person-days) vaccinations. Overall, children did not have higher risks of febrile seizures during the 0 to 7 days after the 3 vaccinations vs a reference cohort of children who were not within 0 to 7 days of vaccination. However, a higher risk of febrile seizures was found on the day of the first (HR, 6.02; 95% CI, 2.86-12.65) and on the day of the second (HR, 3.94; 95% CI, 2.18-7.10), but not on the day of the third vaccination (HR, 1.07; 95% CI, 0.73-1.57) vs the reference cohort. On the day of vaccination, 9 children were diagnosed with febrile seizures after the first (5.5 per 100,000 person-days), 12 children after the second (5.7 per 100,000 person-days), and 27 children after the third (13.1 per 100,000 person-days) vaccinations. The relative incidences from the SCCS study design were similar to the cohort study design. Within 7 years of follow-up, 131 unvaccinated children and 2117 vaccinated children were diagnosed with epilepsy, 813 diagnosed between 3 and 15 months (2.4 per 1000 person-years) and 1304 diagnosed later in life (1.3 per 1000 person-years). After vaccination, children had a lower risk of epilepsy between 3 and 15 months (HR, 0.63; 95% CI, 0.50-0.79) and a similar risk for epilepsy later in life (HR, 1.01; 95% CI, 0.66-1.56) vs unvaccinated children. CONCLUSIONS DTaP-IPV-Hib vaccination was associated with an increased risk of febrile seizures on the day of the first 2 vaccinations given at 3 and 5 months, although the absolute risk was small. Vaccination with DTaP-IPV-Hib was not associated with an increased risk of epilepsy.

[1]  H. Hallander,et al.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.

[2]  U. Stephani,et al.  A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome , 2011, Epilepsia.

[3]  J. Olsen,et al.  MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. , 2004, JAMA.

[4]  J. Olsen,et al.  The Danish National Hospital Register is a valuable study base for epidemiologic research in febrile seizures. , 2006, Journal of clinical epidemiology.

[5]  J. Iskander,et al.  Lack of Association Between Acellular Pertussis Vaccine and Seizures in Early Childhood , 2010, Pediatrics.

[6]  M. Melbye,et al.  Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. , 2004, Vaccine.

[7]  Patrick Musonda,et al.  Tutorial in biostatistics: the self‐controlled case series method , 2006, Statistics in medicine.

[8]  I. Scheffer,et al.  Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study , 2010, The Lancet Neurology.

[9]  Hodes,et al.  The Risk of Seizures After Receipt of Whole-Cell Pertussis or Measles , Mumps , and Rubella Vaccine , 2001 .

[10]  C. Ounsted,et al.  VACCINATION AGAINST WHOOPING-COUGH , 1977, The Lancet.

[11]  A Alioum,et al.  Modelling age-specific risk: application to dementia. , 1998, Statistics in medicine.

[12]  J. Olsen,et al.  The Danish Medical Birth Registry. , 1998, Danish medical bulletin.

[13]  S. Behrman.  Pertussis immunisation and serious acute neurological illness in children , 1981, British medical journal.

[14]  Mogens Vestergaard,et al.  A population-based study of measles, mumps, and rubella vaccination and autism. , 2002, The New England journal of medicine.

[15]  Yrjö Jahnsson,et al.  In Denmark , 1905 .

[16]  C P Farrington,et al.  Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice , 2011, Epidemiology and Infection.

[17]  I. Scheffer,et al.  De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study , 2006, The Lancet Neurology.

[18]  N. Andrews,et al.  Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom. , 2010, Vaccine.

[19]  W Katherine Yih,et al.  Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures , 2010, Pediatrics.

[20]  J. Olsen,et al.  Validation of epilepsy diagnoses in the Danish National Hospital Register , 2007, Epilepsy Research.

[21]  I. Lorenz,et al.  The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine. , 2003, Vaccine.

[22]  P. Mortensen,et al.  The Danish Civil Registration System. A cohort of eight million persons. , 2006, Danish medical bulletin.

[23]  K Reesten M Eldgaard,et al.  A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism , 2002 .

[24]  K. Edwards,et al.  Acellular pertussis vaccines for infants. , 1996, The New England journal of medicine.

[25]  W. Blackwelder,et al.  A placebo-controlled trial of a pertussis-toxoid vaccine. , 1995, The New England journal of medicine.

[26]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[27]  M. Pichichero,et al.  Comparison of 13 acellular pertussis vaccines: adverse reactions. , 1993, Pediatrics.

[28]  M Rush,et al.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.

[29]  D Greco,et al.  A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. , 1996, The New England journal of medicine.

[30]  P. Fine,et al.  Confounding in studies of adverse reactions to vaccines. , 1992, American journal of epidemiology.